Matsuoka, Katsuyoshi http://orcid.org/0000-0002-2950-7660
Yamazaki, Hajime
Nagahori, Masakazu
Kobayashi, Taku
Omori, Teppei
Mikami, Yohei
Fujii, Toshimitsu
Shinzaki, Shinichiro
Saruta, Masayuki
Matsuura, Minoru
Yamamoto, Takayuki
Motoya, Satoshi
Hibi, Toshifumi
Watanabe, Mamoru
Fernandez, Jovelle
Fukuhara, Shunichi
Hisamatsu, Tadakazu
Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
Received: 20 December 2022
Accepted: 1 June 2023
First Online: 23 June 2023
Change Date: 30 May 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00535-024-02116-9
Declarations
:
: Katsuyoshi Matsuoka has received honoraria and research grants from AbbVie, EA Pharma, Pfizer, Mochida, Kyorin, ZERIA, Kissei, Nippon Kayaku, JIMRO, and honoraria from Mitsubishi Tanabe, Takeda, Janssen, MIYARISAN and Celltrion Healthcare. Hajime Yamazaki has received an honorarium from Takeda. Masakazu Nagahori has received honoraria from Mitsubishi Tanabe, Janssen, Kyorin, AbbVie, and research grants from Takeda, Pfizer and Eli Lilly. Taku Kobayashi has received honoraria and research grants from Takeda, Activaid, Alfresa, ZERIA, Kyorin, Nippon Kayaku, Mitsubishi Tanabe, AbbVie, Pfizer, Janssen, JIMRO, EA Pharma, Mochida, Bristol-Myers Squibb, Eli Lilly, honoraria from Thermo Fisher diagnostics, Galapagos, Kissei, and research grants from JMDC, Gilead Sciences, Otsuka and Google Asia Pacific. Teppei Omori has received an honorarium from Takeda. Toshimitsu Fujii has received honoraria and research grants from AbbVie, EA Pharma, Janssen, Kissei, Nichiiko, Takeda, ZERIA, honoraria from Daiichi Sankyo, Kyowa Hakko Kirin, Mitsubishi Tanabe, Mochida, Nippon Kayaku, and research grants from Alfresa, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly and Gilead Sciences. Shinichiro Shinzaki has received honoraria from AbbVie, Alfresa, AstraZeneca, EA Pharma, Eisai, Gilead Sciences, Kissei, Kyorin, Janssen, JIMRO, Mitsubishi Tanabe, Mochida, Nippon Kayaku, Pfizer, Sekisui Medical, Takeda, ZERIA, and a research grant from Sekisui Medical. Masayuki Saruta has received honoraria and scholarship grants from AbbVie, EA Pharma, ZERIA, Kissei, Mochida, and honoraria from Janssen, Mitsubishi Tanabe, Pfizer, Gilead Sciences and Takeda. Minoru Matsuura has received honoraria from Mitsubishi Tanabe, AbbVie, Takeda, Janssen, Kyorin, Mochida, Viatris, Nippon Kayaku, EA Pharma, JIMRO, ZERIA and Aspen. Toshifumi Hibi has received honoraria and research grants from AbbVie, Mitsubishi Tanabe, Mochida, Takeda, ZERIA, Kyorin, JIMRO, honoraria from Sandoz, Gilead Sciences, Janssen, Pfizer, EA Pharma, APO PLUS STATION, Bristol-Myers Squibb, Eli Lilly, Nichi-Iko, and research grants from Otsuka, Alfresa and MIYARISAN. Mamoru Watanabe has received honoraria and research grants from EA Pharma, Mitsubishi Tanabe, Takeda, ZERIA, Kissei, Mochida, AbbVie, honoraria from Pfizer, Boehringer Ingelheim, Gilead Sciences, Janssen, Celltrion Healthcare, JIMRO, Eli Lilly, and research grants from Nippon Kayaku, Kyorin and Alfresa. Jovelle Fernandez was an employee of Takeda when the study was conducted and owns restricted stocks of Takeda and GlaxoSmithKline. Shunichi Fukuhara has received an honorarium from Takeda. Tadakazu Hisamatsu has received honoraria from EA Pharma, AbbVie, Celgene, Janssen, Pfizer, Nichi-Iko, Mitsubishi Tanabe, AbbVie, Kyorin, JIMRO, Mochida, Takeda, research grants from Alfresa and EA Pharma, and scholarship grants from Mitsubishi Tanabe, EA Pharma, AbbVie, JIMRO, ZERIA, Daiichi Sankyo, Kyorin, Nippon Kayaku, Takeda, Pfizer and Mochida. Yohei Mikami, Takayuki Yamamoto, and Satoshi Motoya declare no conflicts of interest.